XFOR
X4 Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
7.09 / 10
Outperform
XFOR displays an adequate fundamental picture (score 7.1/10). Key positives include a favorable PB-ROE (2.5783) and high gross profit margin (83.43%), while weaknesses lie in the current assets turnover ratio (0.2657) and net profit to total profit ratio (100.07%, indicating potential data quirks). Historical back-tests show mixed one-month returns across metrics, with PB-ROE and Asset-MV yielding the most consistent gains (11.47% and 14.99%, respectively). Overall, the company’s asset base and profitability are solid, but working-capital efficiency needs attention.
Analysis Checks(8/10)
Revenue-MV
Value-3.93
Score3/3
Weight37.48%
1M Return20.82%
Value-3.93
Score3/3
Weight37.48%
1M Return20.82%
Gross profit margin (%)
Value83.43
Score2/3
Weight1.80%
1M Return1.47%
Value83.43
Score2/3
Weight1.80%
1M Return1.47%
PB-ROE
Value2.58
Score3/3
Weight17.11%
1M Return11.47%
Value2.58
Score3/3
Weight17.11%
1M Return11.47%
Fixed assets turnover ratio
Value9.52
Score2/3
Weight0.14%
1M Return0.12%
Value9.52
Score2/3
Weight0.14%
1M Return0.12%
Cash-MV
Value-0.07
Score2/3
Weight10.91%
1M Return7.73%
Value-0.07
Score2/3
Weight10.91%
1M Return7.73%
Inventory turnover ratio
Value1.56
Score2/3
Weight-2.76%
1M Return-2.63%
Value1.56
Score2/3
Weight-2.76%
1M Return-2.63%
Profit-MV
Value0.46
Score2/3
Weight10.90%
1M Return7.79%
Value0.46
Score2/3
Weight10.90%
1M Return7.79%
Current assets turnover ratio
Value0.27
Score1/3
Weight-0.55%
1M Return-0.48%
Value0.27
Score1/3
Weight-0.55%
1M Return-0.48%
Asset-MV
Value-0.50
Score3/3
Weight25.29%
1M Return14.99%
Value-0.50
Score3/3
Weight25.29%
1M Return14.99%
Net profit / Total profit (%)
Value100.07
Score0/3
Weight-0.32%
1M Return-0.30%
Value100.07
Score0/3
Weight-0.32%
1M Return-0.30%
Revenue-MV
Value-3.93
Score3/3
Weight37.48%
1M Return20.82%
Value-3.93
Score3/3
Weight37.48%
1M Return20.82%
Inventory turnover ratio
Value1.56
Score2/3
Weight-2.76%
1M Return-2.63%
Value1.56
Score2/3
Weight-2.76%
1M Return-2.63%
Gross profit margin (%)
Value83.43
Score2/3
Weight1.80%
1M Return1.47%
Value83.43
Score2/3
Weight1.80%
1M Return1.47%
Profit-MV
Value0.46
Score2/3
Weight10.90%
1M Return7.79%
Value0.46
Score2/3
Weight10.90%
1M Return7.79%
PB-ROE
Value2.58
Score3/3
Weight17.11%
1M Return11.47%
Value2.58
Score3/3
Weight17.11%
1M Return11.47%
Current assets turnover ratio
Value0.27
Score1/3
Weight-0.55%
1M Return-0.48%
Value0.27
Score1/3
Weight-0.55%
1M Return-0.48%
Fixed assets turnover ratio
Value9.52
Score2/3
Weight0.14%
1M Return0.12%
Value9.52
Score2/3
Weight0.14%
1M Return0.12%
Asset-MV
Value-0.50
Score3/3
Weight25.29%
1M Return14.99%
Value-0.50
Score3/3
Weight25.29%
1M Return14.99%
Cash-MV
Value-0.07
Score2/3
Weight10.91%
1M Return7.73%
Value-0.07
Score2/3
Weight10.91%
1M Return7.73%
Net profit / Total profit (%)
Value100.07
Score0/3
Weight-0.32%
1M Return-0.30%
Value100.07
Score0/3
Weight-0.32%
1M Return-0.30%
Is XFOR undervalued or overvalued?
- XFOR scores 7.09/10 on fundamentals and holds a Discounted valuation at present. Backed by its -131.97% ROE, -279.86% net margin, -2.63 P/E ratio, 4.35 P/B ratio, and -279.57% earnings growth, these metrics solidify its Outperform investment rating.
